Canada Life’s Seres Therapeutics MCRB Stock Holding History

Canada Life’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,130	Closed	-$101K	–	2199
2023 Q3	$101K	Hold	2,130	–	–	﹤0.01%	1959
2023 Q2	$205K	Buy	2,130 +775	+57%	+$84.3K	﹤0.01%	1835
2023 Q1	$154K	Buy	1,355 +1,144	+542%	+$124K	﹤0.01%	1910
2022 Q4	$24K	Hold	211	–	–	﹤0.01%	2221
2022 Q3	$27K	Hold	211	–	–	﹤0.01%	2208
2022 Q2	$14K	Hold	211	–	–	﹤0.01%	2329
2022 Q1	$32K	Hold	211	–	–	﹤0.01%	2265
2021 Q4	$35K	Hold	211	–	–	﹤0.01%	2269
2021 Q3	$29K	Hold	211	–	–	﹤0.01%	2364
2021 Q2	$100K	Hold	211	–	–	﹤0.01%	2088
2021 Q1	$86K	Hold	211	–	–	﹤0.01%	2139
2020 Q4	$103K	Buy	+211	New	+$124K	﹤0.01%	2105
2019 Q2	–	Sell	-339	Closed	-$46K	–	2789
2019 Q1	$46K	Hold	339	–	–	﹤0.01%	2272
2018 Q4	$30K	Buy	+339	New	+$47.4K	﹤0.01%	2493

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Life's MCRB Position: Q4 2023 in Review

Canada Life sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 2,130 shares — an estimated $101K sold.

Canada Life first reported a position in MCRB in Q4 2018 and held it in 14 quarters. The position peaked at $205K in Q2 2023. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

Canada Life reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
Canada Life sold 2,130 Seres Therapeutics shares in Q4 2023, an estimated $101K.
Canada Life first reported a position in Seres Therapeutics in Q4 2018 and held it in 14 quarters.
Canada Life's Seres Therapeutics position peaked at $205K in Q2 2023.
102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.